References in periodicals archive ?
for a generic version of levalbuterol hydrochloride inhalation solution.
In September 2005, Sepracor announced that the FDA received an abbreviated new drug application (ANDA) from Breath Limited for a generic version of levalbuterol hydrochloride inhalation solution.
Food and Drug Administration (FDA) has received an abbreviated new drug application (ANDA) from Breath Limited for a generic version of levalbuterol hydrochloride inhalation solution.